In situ curing polymers provide an alternative to develop off-the shelf therapies. Our lab uses of different monomers and redox chemistries to develop bone fillers for different grafting applications. Other macromers and redox chemistries are also used to develop in situ curing hydrogels for cell encapsulation and delivery.
By inserting hydrolysis-susceptible bonds into a polymeric hydrogel network, our lab is capable of fabricating biodegradable PEG-based hydrogel. We have successfully decoupled the biodegradability with other hydrogel properties, including mechanical properties and water uptake ability. This type of hydrogel can be used for cell encapsulation and release and can also be employed in several different applications, including hydrogel foam wound dressings and bioactive bone grafts.
BPURs are biodegradable polyurethanes synthesized from a “plug-and-play” triblock based on polymer diols in place of standard ring opening polymerization. The versatility of synthesis provides control over the hard segment content allowing for tunable tensile properties and variations in degradation rate. This adaptability provides improved mechanical property control to better mimic tissue while maintaining cytocompatibility. In our lab, BPURs are primarily utilized in electrospinning for cardiovascular and tendon/ligament applications.
The cell extracellular matrix (ECM) consists of biological cues such as growth factors and proteins. In order to communicate with the ECM, cells use surface receptors called integrins that bind to specific amino acid sequences on these molecules. Integrin binding activates signaling pathways that direct cell migration, proliferation, and differentiation, thus controlling cell behavior and function. Currently, there is great interest in designing biomaterials with ECM proteins to target integrins and control cell fate to promote regenerative processes. These biomaterials present a novel class of materials that circumvent many of the problems that can be associated with growth factor delivery such as supraphysiological doses and high cost.